🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.8532
+0.0166 (1.98%)
At close: Nov 18, 2026, 4:00 PM EST
0.8532
0.00 (0.00%)
After-hours: Nov 18, 2026, 4:00 PM EST

Marker Therapeutics Revenue

Marker Therapeutics had revenue of $1.29M in the quarter ending September 30, 2026, with 4.87% growth. This brings the company's total for the last twelve months to $3.83M, down -18.43% year-over-year. In the year 2025, Marker Therapeutics had annual revenue of $3.55M, down -46.19%. That makes Marker Therapeutics the 42,119th largest company in the world by revenue and 5,706th in the United States.

Revenue (ttm)
$3.83M
Revenue Growth
-18.43%
P/S Ratio
6.13
Revenue / Employee
$462,746
Employees
5
Market Cap
14.23M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.55M-3.04M-46.19%
Dec 31, 20246.59M3.28M99.06%
Dec 31, 20233.31M-5.70M-63.26%
Dec 31, 20229.01M7.77M625.90%
Dec 31, 20211.24M774.93K166.01%
Dec 31, 2020466.79K253.59K118.95%
Dec 31, 2019213.19K7.20K3.50%
Dec 31, 2018205.99K22.93K12.53%
Dec 31, 2017183.06K-48.14K-20.82%
Dec 31, 2016231.20K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.